Bowie Capital Management LLC Has $100.60 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Bowie Capital Management LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.5% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 172,058 shares of the healthcare conglomerate’s stock after selling 6,213 shares during the quarter. UnitedHealth Group accounts for 5.2% of Bowie Capital Management LLC’s investment portfolio, making the stock its 6th biggest holding. Bowie Capital Management LLC’s holdings in UnitedHealth Group were worth $100,599,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of the stock. Mirabella Financial Services LLP acquired a new stake in UnitedHealth Group in the 3rd quarter valued at $235,000. Hancock Whitney Corp increased its position in shares of UnitedHealth Group by 17.3% during the third quarter. Hancock Whitney Corp now owns 9,473 shares of the healthcare conglomerate’s stock worth $5,539,000 after acquiring an additional 1,400 shares in the last quarter. Truvestments Capital LLC boosted its stake in UnitedHealth Group by 13.0% during the 3rd quarter. Truvestments Capital LLC now owns 591 shares of the healthcare conglomerate’s stock valued at $346,000 after purchasing an additional 68 shares during the last quarter. Loomis Sayles & Co. L P raised its stake in shares of UnitedHealth Group by 0.7% in the third quarter. Loomis Sayles & Co. L P now owns 653,503 shares of the healthcare conglomerate’s stock worth $382,091,000 after purchasing an additional 4,251 shares during the last quarter. Finally, Boston Family Office LLC grew its holdings in UnitedHealth Group by 3.6% during the third quarter. Boston Family Office LLC now owns 5,191 shares of the healthcare conglomerate’s stock worth $3,035,000 after buying an additional 178 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE UNH traded up $15.02 during trading hours on Monday, reaching $605.89. 689,684 shares of the stock traded hands, compared to its average volume of 3,857,332. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The company’s 50-day simple moving average is $582.63 and its two-hundred day simple moving average is $553.30. The company has a market capitalization of $557.59 billion, a P/E ratio of 38.49, a price-to-earnings-growth ratio of 1.73 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same quarter last year, the firm earned $6.56 EPS. The firm’s quarterly revenue was up 9.2% compared to the same quarter last year. Equities research analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.39%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Analysts Set New Price Targets

UNH has been the subject of a number of recent analyst reports. KeyCorp started coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective for the company. UBS Group dropped their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. HSBC lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Hsbc Global Res lowered shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Finally, Bank of America reduced their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.